61314-0240
JUBBONTI
Denosumab
INJECTION
Subcutaneous
DENOSUMAB
60.0
mg/mL
61314-0240-63
1 SYRINGE in 1 CARTON (61314-240-63) / 1 mL in 1 SYRINGE
June 2, 2025
Immunotherapy
Monoclonal Antibody
RANKL
In Use